Gene Therapy and Biologic Analgesics
Commercial sector
Gene Therapy and Biologic Analgesics
Developers of gene therapies (viral vector-delivered transgenes, epigenome regulators, RNA therapeutics) or protein biologics (Fc-fusions, antibodies, engineered peptides) that modulate pain pathways through long-acting or disease-modifying mechanisms rather than conventional small-molecule pharmacology.
Companies17
Commercial products17
Technology classes1
Countries8
Patents171
Profiled companies
Products
- OlipassSouth Korea2
- Korro BioUnited States2
- AfaSciUnited States1
- NeurocarrusUnited States2
- Sekkei Bio Private LimitedIndia1
- Tafalgie TherapeuticsFrance4
+ 11 more